Kabra Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE323K01017
  • NSEID:
  • BSEID: 524322
INR
22.22
-0.64 (-2.8%)
BSENSE

Jul 08, 02:08 PM

BSE+NSE Vol: 42.65 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryKabra Drugs VS Pharmaceuticals & Biotechnology
 
1D
-2.8%
-1.81%
1W
-2.63%
-0.2%
1M
2.44%
4.41%
YTD
-27.27%
-9.92%
1Y
6.67%
-8.3%
3Y
311.48%
17.6%
5Y
323.24%
46.03%
10Y
142.84%
183%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.65%
0%
-21.65%
6 Months
-22.33%
0%
-22.33%
1 Year
6.67%
0%
6.67%
2 Years
167.71%
0%
167.71%
3 Years
311.48%
0%
311.48%
4 Years
0%
0%
0.0%
5 Years
323.24%
0%
323.24%

Kabra Drugs for the last several years.

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available